RhumbLine Advisers’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-31,890
| Closed | -$118K | – | 2831 |
|
|
2017
Q4 | $118K | Sell |
31,890
-7,254
| -19% | -$26.8K | ﹤0.01% | 2755 |
|
|
2017
Q3 | $160K | Buy |
39,144
+750
| +2% | +$3.07K | ﹤0.01% | 2808 |
|
|
2017
Q2 | $143K | Buy |
+38,394
| New | +$143K | ﹤0.01% | 2849 |
|
|
2016
Q2 | – | Sell |
-16,409
| Closed | -$125K | – | 3062 |
|
|
2016
Q1 | $125K | Buy |
16,409
+29
| +0.2% | +$221 | ﹤0.01% | 2857 |
|
|
2015
Q4 | $218K | Buy |
16,380
+1,244
| +8% | +$16.6K | ﹤0.01% | 2749 |
|
|
2015
Q3 | $249K | Buy |
15,136
+608
| +4% | +$10K | ﹤0.01% | 2663 |
|
|
2015
Q2 | $326K | Buy |
14,528
+1,101
| +8% | +$24.7K | ﹤0.01% | 2604 |
|
|
2015
Q1 | $131K | Buy |
13,427
+3,892
| +41% | +$38K | ﹤0.01% | 2913 |
|
|
2014
Q4 | $109K | Buy |
9,535
+467
| +5% | +$5.34K | ﹤0.01% | 2949 |
|
|
2014
Q3 | $104K | Hold |
9,068
| – | – | ﹤0.01% | 2923 |
|
|
2014
Q2 | $176K | Buy |
+9,068
| New | +$176K | ﹤0.01% | 2880 |
|